Homology Medicines Revenue and Competitors
Claim your profile
Estimated Revenue & Valuation
- Homology Medicines's estimated annual revenue is currently $3.7M per year.
- Homology Medicines's estimated revenue per employee is $23,742
- Homology Medicines's total funding is $187M.
- Homology Medicines's current valuation is $210.9M. (January 2022)
Employee Data
- Homology Medicines has 155 Employees.
- Homology Medicines grew their employee count by -9% last year.
Homology Medicines Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $13.8M | 73 | -39% | $107.3M | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $3.1M | 26 | 63% | N/A | N/A |
#4 | $29.6M | 125 | 18% | $351M | N/A |
#5 | $15.8M | 84 | -18% | $312.8M | N/A |
#6 | $0.5M | 7 | 17% | N/A | N/A |
#7 | $235M | 269 | -43% | $340.9M | N/A |
#8 | $2.2M | 28 | 4% | N/A | N/A |
#9 | $0.6M | 10 | -9% | N/A | N/A |
#10 | $0.5M | 9 | 29% | N/A | N/A |
What Is Homology Medicines?
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
keywords:N/A
$187M
Total Funding
155
Number of Employees
$3.7M
Revenue (est)
-9%
Employee Growth %
$210.9M
Valuation
N/A
Accelerator
Homology Medicines News
2022-04-17 - Homology Medicines Announces Promotion of Albert ...
BEDFORD, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today...
2022-04-17 - Homology Medicines Announces Promotion of Albert ...
BEDFORD, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today...
Other Companies in Bedford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $43.2M | 157 | -2% | N/A |
#2 | $26.5M | 160 | -12% | N/A |
#3 | $62.7M | 165 | 19% | N/A |
#4 | $77.7M | 167 | -18% | N/A |
#5 | $52M | 170 | 3% | N/A |